Melbourn promotes Derek Solomon

Moves from laboratory manager to operations director

Melbourn Scientific, a UK provider of analytical and formulation contract research services for the pharma and biotech industries, is broadening its management team with the promotion of laboratory manager Derek Solomon to the new role of operations director.

Solomon joined Melbourn Scientific in 2005 and has overseen the expansion of the services portfolio, which included the recent addition of clinical manufacture to its formulation development services.

You may also like

Research & Development

Intertek acquires Melbourn Scientific

Combines advanced capabilities for measuring device/drug interaction with OINDP drug characterisation expertise
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing
A finite resource: helium

A finite resource: helium

Although helium may be the second most abundant element in the universe, here on earth this noble gas is rare and precious. In the pharmaceutical industry helium is used for cryogenic cooling of magnets used for MRI and in gas chromatography
Manufacturing
SCHOTT Pharma and SHL Medical enhance home-based large-volume injections for patients

SCHOTT Pharma and SHL Medical enhance home-based large-volume injections for patients

SCHOTT Pharma and SHL Medical have joined forces to introduce the first large-volume cartridge in an autoinjector
Regulatory
Sanofi expands vaccine manufacturing in Abu Dhabi as NICE backs its diabetes therapy

Sanofi expands vaccine manufacturing in Abu Dhabi as NICE backs its diabetes therapy

Sanofi advances on two fronts: a new Abu Dhabi vaccine innovation centre with AI and mRNA capabilities and UK NICE backing for teplizumab, the first disease-modifying treatment for type 1 diabetes
Research & Development
PharmNovo reports broader therapeutic potential for PN6047

PharmNovo reports broader therapeutic potential for PN6047

PharmNovo AB has announced new preclinical findings supporting the potential of PN6047 in migraine and opioid withdrawal syndrome. The findings were generated through the company's NIDA-funded collaboration with researchers at Washington University School of Medicine
Sustainability
Haier Biomedical introduces higher capacity benchtop centrifuge with rapid pre-cooling

Haier Biomedical introduces higher capacity benchtop centrifuge with rapid pre-cooling

Haier Biomedical – a trusted partner in reliable laboratory equipment – has introduced the LX-155T750R, its latest high-speed, benchtop centrifuge featuring ECO fastBlast pre-cooling technology
You need to be a subscriber to read this article.
Click here to find out more.
Research & Development
Neuropsychiatric medicine reaches an inflexion point: regulation, science and the road to commercial reality

Neuropsychiatric medicine reaches an inflexion point: regulation, science and the road to commercial reality

Shaped by accelerating regulatory support, expanding clinical evidence and growing institutional acceptance, psychedelic medicine is entering a pivotal phase, reports Joel Latham, Chief Executive Officer, President and Director at Incannex Healthcare Inc.
Subscribe now